Literature DB >> 25398485

Polymyxin B infusion leading to cardiac arrest: a case report and literature review.

M B Berie1, M S King, I P Thomsen.   

Abstract

We describe a 52-year-old female patient who developed cardiopulmonary arrest due to neuromuscular paralysis after initiation of polymyxin B for septicemia caused by extended spectrum β-lactamase-producing Klebsiella pneumoniae. Due to emerging antibiotic resistance patterns, use of polymyxins is increasing and an understanding of their toxicity is critical.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25398485     DOI: 10.1007/s15010-014-0704-3

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

1.  Polymyxin use associated with respiratory arrest.

Authors:  Hannah Wunsch; Vivek K Moitra; Mona Patel; Amy L Dzierba
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.

Authors:  Matthew E Falagas; Sofia K Kasiakou
Journal:  Clin Infect Dis       Date:  2005-03-22       Impact factor: 9.079

Review 3.  Polymyxins: wisdom does not always come with age.

Authors:  Zahra Kassamali; John C Rotschafer; Ronald N Jones; Randall A Prince; Larry H Danziger
Journal:  Clin Infect Dis       Date:  2013-07-11       Impact factor: 9.079

Review 4.  Colistin and polymyxin B in critical care.

Authors:  Argyris Michalopoulos; Matthew E Falagas
Journal:  Crit Care Clin       Date:  2008-04       Impact factor: 3.598

5.  Reversible respiratory paralysis associated with polymyxin therapy.

Authors:  L A Lindesmith; R D Baines; D B Bigelow; T L Petty
Journal:  Ann Intern Med       Date:  1968-02       Impact factor: 25.391

6.  Acute respiratory failure secondary to polymyxin-B inhalation.

Authors:  F E Wilson
Journal:  Chest       Date:  1981-02       Impact factor: 9.410

7.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

8.  Is it safe to use carbapenems in patients with a history of allergy to penicillin?

Authors:  Manica Sodhi; Sandra S Axtell; Joyce Callahan; Raja Shekar
Journal:  J Antimicrob Chemother       Date:  2004-10-14       Impact factor: 5.790

9.  Neuromuscular block by antibiotics: polymyxin B.

Authors:  C Lee; D Chen; E L Nagel
Journal:  Anesth Analg       Date:  1977 May-Jun       Impact factor: 5.108

10.  Neurotoxicity in patients treated with intravenous polymyxin B: Two case reports.

Authors:  Lenny Weinstein; Thien-Ly Doan; Miriam A Smith
Journal:  Am J Health Syst Pharm       Date:  2009-02-15       Impact factor: 2.637

View more
  1 in total

1.  Severe Infusion-Related Adverse Events and Renal Failure in Patients Receiving High-Dose Intravenous Polymyxin B.

Authors:  Josiane F John; Diego R Falci; Maria Helena Rigatto; Renata D Oliveira; Thaysa G Kremer; Alexandre P Zavascki
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.